Qaytona is free while it's in beta — Get started

Ingredients

Luteolin

Snapshot

IndicationsContraindications
  • Post-COVID-19 olfactory dysfunction1
  • Long COVID symptoms2, 3
  • Autism spectrum disorder behavior4
  • Brain fog5
  • Cardiometabolic parameters6
  • Anticoagulant therapy7
  • Soy allergy7
  • Fish allergy7
  • Peanut allergy7

Luteolin is a flavone found in celery, parsley, chamomile, and other herbs8. It acts through antioxidant and anti-inflammatory effects, including inhibition of microglia and mast cells5. That neuroinflammation rationale drives supplementation for brain fog, behavior in autism spectrum disorder, and persistent symptoms after coronavirus disease 2019 (COVID-19)5. A chlorogenic acid combination has also been studied for cardiometabolic parameters in pre-obesity.

Controlled evidence is narrow. In a 2023 randomized trial of patients with persistent smell loss after COVID-19, palmitoylethanolamide (PEA) co-ultramicronized with luteolin plus olfactory training produced greater recovery than either alone1. Autism data come from an open-label pilot, and diabetes claims rest largely on preclinical work. In a 2026 observational cohort of diabetic adults, higher luteolin intake was associated with lower kidney damage prevalence and better survival; no trial has tested this. Products are mostly capsules and often paired with PEA; low oral bioavailability is the main formulation issue, see Form comparison.

Per United States product labels, some advise consulting a doctor before use with anticoagulant medications7.

Last updated October 17, 2026. Read how we make monographs.

In the full monograph

37 sources, 22 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.pubmed.ncbi.nlm.nih.govDi Stadio, Gallina, Cocuzza et al. · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023 · Pubmed
  2. 2Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome.pubmed.ncbi.nlm.nih.govVersace, Ortelli, Dezi et al. · Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023 · Pubmed
  3. 3What Is the Role of Palmitoylethanolamide Co-Ultramicronized with Luteolin on the Symptomatology Reported by Patients Suffering from Long COVID? A Retrospective Analysis Performed by a Group of General Practitioners in a Real-Life Setting.pubmed.ncbi.nlm.nih.govPirro, Ferri, Piccioni et al. · Nutrients · 2023 · Pubmed
  4. 4An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders.pubmed.ncbi.nlm.nih.govTaliou, Zintzaras, Lykouras et al. · Clinical therapeutics · 2013 · Pubmed
  5. 5Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.pubmed.ncbi.nlm.nih.govTheoharides, Stewart, Hatziagelaki et al. · Frontiers in neuroscience · 2015 · Pubmed
  6. 6A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study.pubmed.ncbi.nlm.nih.govTerzo, Amato, Magán-Fernández et al. · Nutrients · 2023 · Pubmed
  7. 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
  8. 8The Novel Approaches to Extraction Techniques, Drug Delivery Technologies, Pharmacological Applications, Patents of the Potent Flavonoid 'Luteolin': An Appraisal.pubmed.ncbi.nlm.nih.govAkanksha, Kumar, Aqil et al. · Chemistry & biodiversity · 2025 · Pubmed